Aeglea: Q2 Earnings Snapshot

Associated Press Finance
1 min read
0

AUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Aeglea Biotherapeutics Inc. (AGLE) on Friday reported a loss of $217.1 million in its second quarter.

On a per-share basis, the Austin, Texas-based company said it had a loss of $2.27. Losses, adjusted for non-recurring costs, came to $1.66 per share.

The biopharmaceutical company posted revenue of $688,000 in the period.

The company's shares closed at 52 cents. A year ago, they were trading at 46 cents.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGLE at https://www.zacks.com/ap/AGLE

Advertisement

Recommended Stories